had valuable technology at our disposal,
but that we would have to use it judi-ciously.
we set up the california stem cell treatment Center for the investiga-tiona use of stromal vascular fraction and we obtaind Institutionl reviw board - approval to study the safety and ef-ficacy of our deployments.
IRB'are gov-erned by our Office of Human Research Protections (a division of the Department) of Health and Human Services.